Gain Therapeutics股价在宣布公开发行后下跌

英为财情
Jul 16, 2025

Investing.com -- Gain Therapeutics Inc (NASDAQ:GANX)股价下跌11%,此前这家临床阶段生物技术公司宣布计划进行普通股和购买普通股权证的承销公开发行。 该公司专注于开发变构小分子疗法,计划将所得款项用于推进其主要产品候选GT-02287的临床和非临床开发,该产品用于治疗神经退行性疾病,包括GBA1帕金森病,以及用于一般公司用途。 Gain预计将...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10